Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Canadian universities provide world-recognized training in research and leadership for their graduate students...

We would like to update you on new Board of Directors of CBS. As of June 21st 2019, We have President Nima Khadem Mohtaram University of Waterloo 2019 - 2020 President Elect Kibret Mequanint Western University 2019 - 2020 - President 2020-2021 Past President Sophie Lerouge Ecole de Technologie Superieure ETS - CRCHUM 2019-2020 Board Members Fabio Variola University of Ottawa 2019-2021 Isabelle Catelas University of Ottawa 2018-2020 Thomas Willett University of Waterloo 2018-2020 Milica Radisic University of Toronto 2018-2020 Mohsen Akbari University of Victoria 2018-2020 Student Board Member Laura McKiel Queen s University 2019-2020

As you may have noticed already, the WBC2020 Executive Committee is calling for workshop proposals. We hereby would like to take this opportunity to encourage you to submit your proposals before the deadline of June 30th 2019...

Dear CBS members, Our Annual General Meeting will take place during the CBS2019 on May 22nd, at 12 15 in the Suzor Room...

Dental composites have been used for over 50 years as restorative materials. Compared with dental amalgam, these trigger less safety concerns and provide improved aesthetics...

Sutures penetrate tissues to close wounds. This process leads to inflammatory responses, prolongs healing time, and increase operation complexity...

Several adhesives found in nature perform in ways that synthetic adhesives do not yet match. For example, even though many aquatic organisms have adapted to adhere to surfaces in aqueous environments, it remains an engineering challenge to synthesize biocompatible adhesives that are effective in wet conditions...

Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...

Treatment for diseases in the central nervous system are challenging because of the physical and biochemical barriers that comprise the blood brain barrier and the blood-spinal cord barrier BSCB 1 ...